Trends in Intra-Aortic Balloon Pump Use in Cardiogenic Shock in the Post-SHOCK II Trial Era

Tie E Nan,D Dinh,D Clark,A Ajani,A Brennan,N Cohen,M Dagan,J Shaw,M Sebastian,M Freeman,E Oqueli,C Reid,D Kaye,D Stub,S Duffy

doi:10.1016/j.hlc.2021.06.512

Trends in Intra-Aortic Balloon Pump Use in Cardiogenic Shock in the Post-SHOCK II Trial Era

Tie E Nan, D Dinh + Show 13 more

https://doi.org/10.1016/j.hlc.2021.06.512

Copy DOI

Journal: Heart Lung and Circulation	Publication Date: Jan 1, 2021
Citations: 1

Affiliation: Alfred Health, Austin Health, University of Melbourne, Royal Melbourne Hospital, Barwon Health, Eastern Health, Ballarat Health Services, Western Health

#Intra-Aortic Balloon Pump Use #Balloon Pump Use + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Myocardial infarction complicated by cardiogenic shock (MI-CS) has a poor prognosis, even with early revascularisation. Previously, intra-aortic balloon pump (IABP) use was thought to improve outcomes, but the SHOCK-II trial (Intraaortic Balloon Pump in Cardiogenic Shock II) found no survival benefit.

Full Text